<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00927134</url>
  </required_header>
  <id_info>
    <org_study_id>PedsZ端rich_GT05</org_study_id>
    <nct_id>NCT00927134</nct_id>
  </id_info>
  <brief_title>Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children</brief_title>
  <acronym>XCGDinChildren</acronym>
  <official_title>Phase I/II Gene Therapy Study for X-linked Chronic Granulomatous Disease in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Goethe University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the side effects and risks after infusion of retroviral
      gene corrected autologous CD34+ cells of the peripheral blood of chemotherapy conditioned
      (busulphan) children with chronic granulomatous disease (CGD). Also gene corrected and
      functional active granulocytes in the peripheral blood and the engraftment in the bone marrow
      of the patients will be monitored an documented.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2004</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>eradication of pre-existing therapy refractory bacterial and/or fungal infections</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reconstitution of ROS production by peripheral blood cells</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">2</enrollment>
  <condition>Chronic Granulomatous Disease</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>retroviral SF71-gp91phox transduced CD34+ cells</intervention_name>
    <description>autologous ex-vivo transduced (SF71-gp91phox)CD34+ cells</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  x-linked Chronic Granulomatous Disease

          -  history of life-threatening severe infections

          -  no HLA-matched related or unrelated donor

          -  therapy resistent life threatening infections/organ dysfunction

          -  no other treatment options e.g. HSCT

        Exclusion Criteria:

          -  &gt; 18 years of age

          -  HIV infection

          -  life expectancy &gt; 2 years

          -  infections treatable by conventional therapy (antibiotics, antimycotics, allogeneic
             granulocytes)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reinhard Seger, Prof Dr med</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Children's Hospital, Zurich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janine Reichenbach, PD Dr med</last_name>
    <role>Study Chair</role>
    <affiliation>University Children's Hospital, Zurich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulrich Siler, Dr rer nat</last_name>
    <role>Study Chair</role>
    <affiliation>University Children's Hospital, Zurich</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manuel Grez, Dr rer nat</last_name>
    <role>Study Chair</role>
    <affiliation>Georg Speyer Research Institute, Frankfurt a.M.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Children's Hospital</name>
      <address>
        <city>Z端rich</city>
        <zip>CH-8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, K端hlcke K, Schilz A, Kunkel H, Naundorf S, Brinkmann A, Deichmann A, Fischer M, Ball C, Pilz I, Dunbar C, Du Y, Jenkins NA, Copeland NG, L端thi U, Hassan M, Thrasher AJ, Hoelzer D, von Kalle C, Seger R, Grez M. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med. 2006 Apr;12(4):401-9. Epub 2006 Apr 2.</citation>
    <PMID>16582916</PMID>
  </reference>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2009</study_first_submitted>
  <study_first_submitted_qc>June 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2009</study_first_posted>
  <last_update_submitted>September 26, 2011</last_update_submitted>
  <last_update_submitted_qc>September 26, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Granulomatous Disease in children (=or&lt; 18 years)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Granuloma</mesh_term>
    <mesh_term>Granulomatous Disease, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

